Notice of National Cancer Institute (NCI) Participation in PA-13-359 "Nutrition and Alcohol-Related Health Outcomes (R01)"

Notice Number: NOT-CA-14-002

Key Dates
Release Date: October 30, 2013

Related Announcements
PA-13-359

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating in PA-13-359, entitled "Nutrition and Alcohol-Related Health Outcomes (R01)."

Part 1. Overview Information, the Components of Participating Organizations section has been revised as shown below to include the NCI:

Components of Participating Organizations
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Office of Dietary Supplements (ODS)
National Cancer Institute (NCI)

Part 1. Overview Information, the Catalog of Federal Domestic Assistance (CFDA) Number(s) has been revised as shown below to include the appropriate number for the NCI, which is 93.393:

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.273, 93.393

In Part 2. Full Text of Announcement, Section I. Funding Opportunity Description, the following examples regarding the specific interests of the NCI in this funding opportunity are added:

Examples of research studies that would be of interest to the NCI include, but are not necessarily limited to, those designed and conducted to:

  • identify and characterize gene (or epigene)-environment (diet and alcohol) interactions that influence risk for cancer in humans;
  • determine the role(s) of nutrition-alcohol interactions in the fetal origins of chronic disease, including cancer;
  • identify drinking and eating patterns that interact to influence cancer risk;
  • explore the relationship(s) between alcohol consumption, gene regulation (such as microRNA expression and/or epigenetic modulation), and cancer risk;
  • examine the relationship(s) between chronic alcohol ingestion, weight gain (and obesity), and cancer risk; and/or
  • examine any associations between diet, alcohol consumption, gut microbiota, metabolism, and cancer risk (and prevention) in humans and/or in animal models.

In Part 2. Section VII. Agency Contacts, under Scientific/Research Contact(s), the name and contact information for the NCI's program representative are added as follows:

Sharon Ross, Ph.D., M.P.H.
Division of Cancer Prevention
National Cancer Institute (NCI)
Telephone: 240-276-7124
Email: rosssha@mail.nih.gov

In Part 2. Section VII. Agency Contacts, under Financial/Grants Management Contact(s), the name and contact information for the NCI's financial/grants management contact are added as follows:

Amy Knight
National Cancer Institute (NCI)
Telephone: 301-631-3007
Email: knighta@mail.nih.gov

All other aspects of PA-13-359 remain the same.

Inquiries

Please direct all inquiries to:

Sharon Ross, Ph.D., M.P.H.
Division of Cancer Prevention
National Cancer Institute (NCI)
Telephone: 240-276-7124
Email: rosssha@mail.nih.gov